Read the corresponding article: https://peptideresearch.us/cjc-1295-and-ipamorelin/

Click here to join our Discord: Real Peptide Talk
Shop Research Compounds: https://wholesalepeptides.us
Visit our blog: https://peptideresearch.us
Join our Newsletter list: https://peptideresearch.us/newsletter

In this episode of The Peptide Research Podcast, we explore the growing conversation surrounding CJC-1295 and Ipamorelin peptides and why this combination has become one of the most discussed growth hormone optimizer stacks in the peptide research landscape.

We discuss how researchers are studying the potential synergy between CJC-1295, a growth hormone-releasing hormone analog, and Ipamorelin, a selective ghrelin receptor agonist. The episode covers how these peptides may work through separate biological pathways to support growth hormone signaling, IGF-1 research, muscle preservation, body composition, deep sleep architecture, metabolic efficiency, and tissue recovery.

We also break down the important distinction between CJC-1295 with DAC and CJC-1295 without DAC, including why researchers often focus on preserving natural growth hormone pulses in experimental models. As always, this episode keeps the conversation research-focused, covering potential mechanisms, current limitations, and important safety considerations surrounding research-only peptide use.

If you have been curious about CJC-1295 and Ipamorelin peptides and why this stack continues gaining attention in growth hormone, recovery, and longevity research discussions, this episode provides a clear overview of the current research landscape.